Literature DB >> 1159089

Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone.

D C Dale, A S Fauci, I V Guerry D, S M Wolff.   

Abstract

To study the potential application of glucocorticosteroid administration for the measurement of the bone marrow neutrophil reserve response, blood neutrophil count changes were measured in normal subjects after the administration of intravenous hydrocortisone (25, 50, 100, 200, and 400 mg) and oral prednisone (5, 10, 20, 40, and 80 mg). The upper three doses of both steroids increased the blood neutrophil count by approximately 4,000 cells/mm3. The neutrophilia occurring after hydrocortisone (200 mg) and/or prednisone (40 mg) was compared with that observed after endotoxin (0.8 ng/kg) and etiocholanolone (0.1 mg/kg) in 14 normal subjects, 7 patients with Wegener's granulomatosis on cyclophosphamide therapy and 10 patients with chronic idiopathic neutropenia. The normal responses (mean increase of blood neutrophils/mm3 above base line +/- 1 SEM) were: hydrocortisone 4,220 +/- 320, prednisone 4,610 +/- 360, endotoxin 6,060 +/- 880, and etiocholanolone 3,780 +/- 440. In the patient studies, etiocholanolone gave the smallest mean responses, but, in general, the results were similar for all agents. These data indicate that these glucocorticosteroids can be used as equivalent agents to endotoxin and etiocholanolone for measuring the neutrophil reserve response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159089      PMCID: PMC301935          DOI: 10.1172/JCI108159

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects.

Authors:  J W ATHENS; O P HAAB; S O RAAB; A M MAUER; H ASHENBRUCKER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1961-06       Impact factor: 14.808

2.  Granulocyte responses of children to bacterial endotoxin.

Authors:  L G THATCHER; N J SMITH
Journal:  J Pediatr       Date:  1963-04       Impact factor: 4.406

3.  Evaluation of marrow granulocytic reserves in normal and disease states.

Authors:  C G CRADDOCK; S PERRY; L E VENTZKE; J S LAWRENCE
Journal:  Blood       Date:  1960-06       Impact factor: 22.113

4.  The effect of massive doses of cortisone on the peripheral blood and bone marrow of the mouse.

Authors:  H QUITTNER; N WALD; L N SUSSMAN; W ANTOPOL
Journal:  Blood       Date:  1951-06       Impact factor: 22.113

5.  Comparison of leukocyte response of ACTH and bacterial pyrogen.

Authors:  B SOYLEMEZOGLU; J A WELLS
Journal:  Proc Soc Exp Biol Med       Date:  1951-05

6.  Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections.

Authors:  D C Dale; A S Fauci; S M Wolff
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

7.  Studies on the neutropenia of cancer chemotherapy.

Authors:  A S Deinard; I E Fortuny; A Theologides; G L Anderson; J Boen; B J Kennedy
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

8.  Studies of the neutropenia of acute malaria.

Authors:  D C Dale; S M Wolff
Journal:  Blood       Date:  1973-02       Impact factor: 22.113

9.  Etiocholanolone in the evaluation of marrow reserves in patients receiving cytotoxic agents.

Authors:  J M Vogel; H R Kimball; S M Wolff; S Perry
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

10.  Immunosuppressive therapy: guidelines for drug dosage. Depression of bone marrow granulocyte reserves in systemic lupus erythematosus.

Authors:  H E Paulus; R Okun; J J Calabro
Journal:  Arthritis Rheum       Date:  1972 Jan-Feb
View more
  47 in total

1.  The etiology and management of leukopenia.

Authors:  V W Ing
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

2.  Chemiluminescence of neutrophils in patients with glomerulonephritis treated with methylprednisolone.

Authors:  J Kuźniar; W Sajewicz; W Kopeć; Z Hruby
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

3.  Social regulation of leukocyte homeostasis: the role of glucocorticoid sensitivity.

Authors:  Steve W Cole
Journal:  Brain Behav Immun       Date:  2008-04-03       Impact factor: 7.217

4.  Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.

Authors:  Saleh Rachidi; Kristin Wallace; John M Wrangle; Terry A Day; Anthony J Alberg; Zihai Li
Journal:  Head Neck       Date:  2015-09-28       Impact factor: 3.147

Review 5.  The leucocytosis of exercise. A review and model.

Authors:  D A McCarthy; M M Dale
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

6.  Effects of chronic mental stress and atherogenic diet on the immune inflammatory environment in mouse aorta.

Authors:  Maria Cecilia Garibaldi Marcondes; Viktor Zhukov; Henry Bradlow; Manuel Sanchez-Alavez; Alejandro Sanchez-Alavez Gonzalez; Linda K Curtiss; Bruno Conti
Journal:  Brain Behav Immun       Date:  2011-06-22       Impact factor: 7.217

7.  A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.

Authors:  T Kurz; M Weiner; C Skoglund; S Basnet; P Eriksson; M Segelmark
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

8.  Septic complications of corticosteroid administration after central nervous system trauma.

Authors:  E J DeMaria; W Reichman; P R Kenney; J M Armitage; D S Gann
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

9.  A positive fever response in Agama agama and Sceloporus orcutti (Reptilia: Agamidae and Iguanidae).

Authors:  C E Ortega; D S Stranc; M P Casal; G M Hallman; A E Muchlinski
Journal:  J Comp Physiol B       Date:  1991       Impact factor: 2.200

10.  Drug-induced hematologic syndromes.

Authors:  David M Mintzer; Shira N Billet; Lauren Chmielewski
Journal:  Adv Hematol       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.